US Seeks Global Deal to Stabilize Rare Earth Mineral Prices
The Trump administration plans to build international consensus on rare earth pricing to counter China's market dominance and protect Western refiners from price undercutting.
NOTRELOAD AI
Apple's Record Q1: Can It Last Amid Supply Chain Woes?
Apple delivered record-breaking Q1 results with $143.8B revenue and 38% China growth, but memory shortages and supply constraints threaten future margins.
Jefferies Starts Coverage on Definium Therapeutics with Buy Rating and $30 Target
Jefferies initiated coverage on Definium Therapeutics with a Buy rating, citing strong Phase IIb results for its anxiety drug DT120 and high confidence ahead of Phase III trials.
Quince Therapeutics Halts A-T Drug Development After Phase 3 Trial Miss
Quince Therapeutics ends eDSP development for ataxia-telangiectasia after Phase 3 NEAT trial fails primary endpoints. Stock plunges 91% as company explores strategic options.
Elon Musk Eyes Empire Consolidation: SpaceX Explores Mergers with Tesla and xAI
SpaceX is weighing potential mergers with both Tesla and xAI as Elon Musk considers consolidating his business empire ahead of a blockbuster IPO potentially valuing SpaceX at $1.5 trillion.
Fractyl's Weight Maintenance Study Shows Modest Results After GLP-1 Stoppage
Fractyl Health's (GUTS) REMAIN-1 study reveals limited weight maintenance benefits with Revita procedure after stopping GLP-1 medications, raising questions about effectiveness.